Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
URIFINE-B6
- Development stage
- Unknown
- Lead developer
- Invision Medi Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
URIFINE-B6 is an oral syrup formulation developed and marketed by Invision Medi Sciences, an Indian pharmaceutical company. It is a combination product typically containing potassium citrate, magnesium citrate, and pyridoxine hydrochloride (Vitamin B6). The product is indicated for the management of kidney stones (urolithiasis), renal tubular acidosis, and hypocitraturia. The citrate components function as systemic alkalizing agents that increase urinary pH and citrate levels, which inhibits the crystallization of stone-forming salts like calcium oxalate and uric acid. Pyridoxine is included to reduce the endogenous production of oxalate by acting as a cofactor for the enzyme alanine-glyoxylate aminotransferase. As a product of a PCD (Propaganda cum Distribution) pharma model, it is a branded generic version of a well-established therapeutic combination.
- Brand names
- URIFINE-B6URIFINE-B-6URIFINE-B 6URIFINE-B6 SyrupURIFINE-B-6 SyrupURIFINE-B 6 Syrup
02
Targets
SPT (Serine palmitoyltransferase)
Beyond the preview
Go deeper on URIFINE-B6.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on URIFINE-B6.